Vincerx Pharma, Inc. filed an 8-K form with the Securities and Exchange Commission on December 20, 2024, announcing the entry into a binding term sheet with Oqory, Inc., a Delaware corporation, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback